Publication | Closed Access
Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
36
Citations
0
References
1987
Year
Hematological MalignancyLymphoid NeoplasiaAcute LeukaemiaOncologyMedicineSide EffectsHigh-dose Cytosine ArabinosidePharmacotherapyPharmacologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!